Mirae Asset Global Investments Co. Ltd. Has $56.08 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.4% in the fourth quarter, HoldingsChannel reports. The firm owned 114,504 shares of the healthcare conglomerate’s stock after purchasing an additional 10,826 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in UnitedHealth Group were worth $56,084,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. AMF Tjanstepension AB boosted its position in shares of UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after acquiring an additional 121,180 shares during the period. Czech National Bank boosted its position in shares of UnitedHealth Group by 7.3% in the third quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after acquiring an additional 12,721 shares during the period. Hudson Value Partners LLC boosted its position in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the period. Versant Capital Management Inc boosted its position in shares of UnitedHealth Group by 17.8% in the third quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock valued at $591,000 after acquiring an additional 153 shares during the period. Finally, Ignite Planners LLC lifted its position in UnitedHealth Group by 11.2% during the third quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock worth $791,000 after purchasing an additional 136 shares during the period. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $545.08 on Wednesday. The company has a market capitalization of $501.63 billion, a PE ratio of 35.17, a P/E/G ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a 50 day simple moving average of $535.03 and a two-hundred day simple moving average of $565.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business earned $5.83 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on UNH. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Morgan Stanley lowered their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.